Skip to main content
Log in

Calcium metabolism and vitamin D metabolite levels in children receiving anticonvulsant drugs

  • Original Investigations
  • Published:
European Journal of Pediatrics Aims and scope Submit manuscript

Abstract

Calcium metabolism and plasma concentrations of vitamin D metabolites were investigated in 27 children on long-term anticonvulsant therapy. Serum calcium was in the low normal range, phosphorus was normal, parathyroid hormone concentrations and alkaline phosphatase were elevated. Plasma 25-hydroxyvitamin D (25-OH D) and 24,25-dihydroxyvitamin D (24,25-(OH)2D) were decreased, but 1,25-dihydroxyvitamin D (1,25-(OH)2D) was normal when compared with a synchronous control group. The serum concentrations of all anticonvulsant drugs given were measured. The decreases in 25-OH D and 24,25-(OH)2D did not depend on the blood level of a single drug, or any combination of drugs given, or on the duration of therapy. The 25-OH D levels were negatively correlated with the number of different drugs used, which may reflect the severity of the neurologic disorder, and therefore with non-specific factors such as exposure to sunlight, nutrition, or physical activity.

Our data do not support the hypothesis that anticonvulsant drugs act on vitamin D metabolism.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Kruse R (1968) Osteopathien bei antiepileptischer Langzeittherapie. Mschr Kinderheilk 116:378–380

    Google Scholar 

  2. Hahn TJ, Hendin BA, Scharp CR, Boisseau VC, Haddad JG (1975) Serum 25-hydroxycalciferol levels and bone mass in children on chronic anticonvulsant therapy. N Engl J Med 292:550–554

    Google Scholar 

  3. Caspary WF (1972) Inhibition of intestinal calcium transport by diphenylhydantoin in rat duodenum. Naunyn-Schmiedeberg's Arch Pharmacol 274:146–153

    Google Scholar 

  4. Koch H-U, Kraft D, v Herrath D, Schaefer K (1972) Influence of diphenylhydantoin and phenobarbital on intestinal calcium transport in the rat. Epilepsia 13:829–834

    Google Scholar 

  5. Hahn TJ, Birge SJ, Scharp CR, Avioli LV (1972) Phenobarbital-induced alterations in vitamin D metabolism. J Clin Invest 51: 741–748

    Google Scholar 

  6. Norman AW, Bayless JD, Tsai HC (1976) Biologic effects of shortterm phenobarbital treatment on the response to vitamin D and its metabolites in the chick. Biochem Pharmacol 25:163–168

    Google Scholar 

  7. Silver J, Neale G, Thompson GR (1974) Effect of phenobarbitone treatment on vitamin D metabolism in mammals. Clin Sci Mo Med 46:433–448

    Google Scholar 

  8. Weisman Y, Fattal A, Eisenberg Z, Harel S, Spirer Z, Harel A (1979) Decreased serum 24,25-dihydroxyvitamin D concentrations in children receiving chronic anticonvulsant therapy. Br Med J 2:521–523

    Google Scholar 

  9. Jubiz W, Haussler MR, McCain TA, Tolman KG (1977) Plasma 25-dihydroxyvitamin D levels in patients receiving anticonvulsant drugs. J Clin Endocrinol Metab 44:617–621

    Google Scholar 

  10. Mosekilde L, Hansen HH, Christensen MS, Lund B, Sørensen OH, Melsen F, Norman AW (1974) Fractional intestinal calcium absorption in epileptics on anticonvulsant therapy. Acta Med Scand 205:405–409

    Google Scholar 

  11. Stamp TCB, Round JM (1974) Seasonal changes in human plasma levels of 25-hydroxyvitamin D. Nature 247:563–565

    Google Scholar 

  12. Keck E, v Lilienfeld-Toal H, Krüskemper HL (1981) Protein binding assays for 25-hydroxyvitamin D, 24,25-dihydroxyvitamin D, and 1,25-dihydroxyvitamin D in human plasma. J Clin Chem Clin Biochem 19:1043–1050

    Google Scholar 

  13. Grote H, Herbertz L, Kuschak D, Meiertoberens M, Reinauer H (1979) Quantitative Bestimmung von VPA aus Serum mit Hilfe der Dünnfilmglaskapillar-Gaschromatographie. J Clin Chem Clin Biochem 17:157–161

    Google Scholar 

  14. Mosekilde L, Christensen MS, Lund B, Sørensen OH, Melsen F (1977) The interrelationships between serum 25-hydroxycholecalciferol serum parathyroid hormone and bone charges in anticonvulsant osteomalacia. Acta Endocrinol 84:559–565

    Google Scholar 

  15. Richens A, Rowe DJF (1970) Disturbance of calcium metabolism by anticonvulsant drugs. Br Med J 4:73–76

    Google Scholar 

  16. Stamp TCB, Round JM, Rowe DJF, Haddad JG (1972) Plasma levels and therapeutic effect of 25-hydroxycholecalciferol in epileptic patients taking anticonvulsant drugs. Br Med J 4:9–12

    Google Scholar 

  17. Hahn TJ, Hendin BA, Scharp CR, Haddad JG (1972) Effect of chronic anticonvulsant therapy on serum 25-hydroxycalciferol levels in adults. N Engl J Med 287:900–904

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

Dedicated to Prof. Dr. G.-A. von Harnack on occasion of his 65th birthday

Rights and permissions

Reprints and permissions

About this article

Cite this article

Keck, E., Gollnick, B., Reinhardt, D. et al. Calcium metabolism and vitamin D metabolite levels in children receiving anticonvulsant drugs. Eur J Pediatr 139, 52–55 (1982). https://doi.org/10.1007/BF00442080

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00442080

Key words

Navigation